Company intelligence / Profile preview

BioCeryx

San Carlos, California, United Statesbioceryx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

BioCeryx has developed the Sentinel platform to enable rapid, high-quality precision medicine testing at or near the point of care. The system combines advanced fluidics, engineering, and bioinformatics to deliver actionable genomic information with minimal hands-on time and fast turnaround. No specific clinical trial results are reported; the focus is on enabling access to molecular diagnostics.

Therapeutic areas: Other
Modalities: DeviceDiagnostic platform (IVD system)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on BioCeryx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioCeryx.

Explore the full profile